Welcome to the TCT 2023 Press Room!
The Cardiovascular Research Foundation (CRF) is committed to keeping healthcare professionals and the public informed of the latest research news in interventional cardiovascular medicine. On behalf of the TCT media relations team, we look forward to working with you during TCT 2023. You will be able to access all press materials for TCT on this website.
Media, investigators, organizations issuing press releases, and others with access to research accepted for presentation during TCT 2023 are required to abide by the embargo policies governing CRF meetings.
The Cardiovascular Research Foundation (CRF) embargoes information presented as a late-breaking clinical trial, late-breaking clinical science, or featured clinical science. Coverage of these studies is strictly prohibited until the start time of each trial’s official presentation as listed in the TCT 2023 Program on the official TCT 2023 website. No journalist, exhibitor, or university (or affiliated organization or company) may disseminate information until the trial’s official presentation time. All embargo times are listed in Pacific Daylight Time (PDT). There is no official embargo for research presented as an abstract, challenging case, or during an innovation session, but we request that you do not file stories until the meeting begins.
Please note: TCT officially begins on October 23, 2023 at 7:00 AM PDT.
Violation of TCT embargo policies can result in removal of the research from the scientific program, removal of individuals and/or companies from the meeting, and revocation of media credentials.
By accepting a media registration for TCT 2023 or accepting TCT embargoed materials through email, fax, regular mail, thumb drive, or embargoed press room website, journalists acknowledge the embargoed information is for their use in preparing media coverage and they will not distribute or publish the information while the embargo is in effect. The embargo policy also applies to news releases and other communications from outside organizations that include embargoed information scheduled for presentation at TCT.
Social Media Policy
CRF promotes the free exchange and rapid dissemination of research and educational content from all CRF meetings. The slides from CRF-sponsored courses and symposia are immediately posted on TCTMD to facilitate scientific discourse and enhance patient care.
Communicating through social media is welcome and strongly encouraged, provided that embargo rules for late-breaking clinical trials, late-breaking clinical science, and featured clinical research are honored. Photographs, screenshots, images of slides from sessions, and brief audio/video clips can be shared via social media. However, posting or live streaming entire sessions or live cases (the latter to respect patient privacy) and use of any CRF course content for commercial purposes is strictly prohibited.
The official hashtag for TCT 2023 taking place October 23-26 is #TCT2023.
Recording Policy (Audio, Video, And Still Photography)
Photography (non-flash only) and brief audio, video, or screen recording using hand-held equipment for strictly personal, educational, and/or social use (in accordance with CRF’s Social Media Policy) are permitted at all CRF meetings as determined solely by CRF. Substantial portions of posters, slides, and presentations may not be copied or reproduced in any form for sale or commercial use. CRF reserves the right to limit recordings onsite if deemed necessary.
Media must obtain approval and camera tag from CRF before filming, screen recording, or taking photographs for the purpose of original news or social media coverage. Please note that once approval to film and/or photograph is obtained, filming, videotaping, and photography are limited to agreed-upon terms.
Slides are provided to the media to assist in the development of original news coverage only and not for copying, sale or redistribution. Please note that publishing or posting press conference slides, abstracts, posters or substantial portions of these materials is not permitted.